Ginecologia/Obstetrícia

Fluxos menstruais intensos: evidência para ajudar a avaliar as opções de tratamento.

9 Ago, 2022 | 16:58h

Heavy periods: evidence to help you weigh up treatment options – Evidently Cochrane

Artigo original: Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis – Cochrane Library

 

---

Estudo de coorte | Idade da menopausa e risco de insuficiência cardíaca e fibrilação atrial.

9 Ago, 2022 | 16:56h

Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study – European Heart Journal (link para o resumo – $ para o texto completo)

Editorial: Premature menopause and cardiovascular disease: can we blame estrogen? – European Heart Journal

Comunicado de imprensa: Premature menopause is associated with increased risk of heart problems – European Society of Cardiology

 

---

Estudo randomizado | Dexametasona antenatal para parto prematuro tardio (entre 34 e 36 semanas de gestação).

9 Ago, 2022 | 16:44h

Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial – EClinicalMedicine

 

Comentário no Twitter

Does Dexamethasone reduce neonatal mortality or respiratory distress when given to pregnant women at risk of preterm birth between 34 and 36 weeks of gestation? A newly published RCT by the WHO ACTION Collaborators in Lancet.https://t.co/ag1v3nKFkR#EBNeoAlerts#NeoEBM pic.twitter.com/j5x8nN88Fp

— Evidence-Based Neo (@EBNEO) February 13, 2022

 

---

Revisão sistemática | Câncer endometrial e mutações BRCA.

9 Ago, 2022 | 16:42h

Endometrial Cancer and BRCA Mutations: A Systematic Review – Journal of Clinical Medicine

 

---

Estudo randomizado | Seguimento pós-parto de 72 semanas de dolutegravir vs. efavirenz iniciado na gestação.

5 Ago, 2022 | 17:40h

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study – The Lancet HIV

Conteúdos relacionados:

WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations

Week 96 results from a RCT: Efficacy and safety of dolutegravir or darunavir combined with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection.

RCT: Efficacy and safety of switching to the 2-drug regimen Dolutegravir/Lamivudine vs. continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with HIV-1.

RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.

RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.

Randomized controlled trial compared three antiretroviral regimens started in pregnant women with HIV

Randomized Trial: Switching to Dolutegravir/Lamivudine Two-Drug Regimen Noninferior to Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1

 

---

M-A | Pacote de cuidados perioperatórios para prevenção de infecções de sítio cirúrgico.

4 Ago, 2022 | 14:23h

Perioperative care bundles for the prevention of surgical-site infections: meta-analysis – British Journal of Surgery

 

---

M-A | Parto planejado ou manejo expectante na pré-eclâmpsia.

4 Ago, 2022 | 14:22h

Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis – American Journal of Obstetrics & Gynecology

 

Comentário no Twitter

Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis https://t.co/djWXjReZAM pic.twitter.com/UdjsqcXDnH

— AJOG (@AJOG_thegray) July 26, 2022

 

---

Estudo comparativo internacional baseado no Global Burden of Disease | Tendências globais e incidência e mortalidade específicas da idade para câncer de colo do útero de 1990 a 2019.

2 Ago, 2022 | 13:09h

Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease – BMJ Open

 

---

Estudo de coorte | Associação da tecnologia de reprodução assistida com o crescimento e a adiposidade dos descendentes desde a infância até o início da vida adulta.

2 Ago, 2022 | 12:58h

Association of Assisted Reproductive Technology With Offspring Growth and Adiposity From Infancy to Early Adulthood – JAMA Network Open

Comunicado de imprensa: Concerns about effects of fertility treatment on children’s development are unwarranted, large study suggest – University of Bristol

 

Comentário no Twitter

This cohort study found that differences in early growth and adiposity for people conceived via assisted reproductive technology (vs. naturally) were small and reduced with older age. @aelhak19 @DeborahLawlor2 https://t.co/hwdldN6yDf

— JAMA Network Open (@JAMANetworkOpen) July 26, 2022

 

---

Estudo de coorte | Riscos de AVC e doença cardíaca após histerectomia e ooforectomia em mulheres na pré-menopausa.

18 Jul, 2022 | 13:39h

Risks of Stroke and Heart Disease Following Hysterectomy and Oophorectomy in Chinese Premenopausal Women – Stroke

Comentário: Removal of Uterus, Ovaries Poses Extra Cardiovascular Risk for Younger Women – MedPage Today (necessário cadastro gratuito)

 

---